Effectdossier · gearchiveerd kwartaal
WST
West Pharmaceutical Services, Inc. · Healthcare · Medical - Instruments & Supplies
21Gevolgde houders
-1Δ houders
26.99MGehouden aandelen
$7.08BGerapporteerde waarde
+0Nieuwe posities
−2Uitstappen
Momentum-inputs (vergelijkbare managers):
breedte van houders -4.5% ·
aandelenstroom +2.6% ·
netto nieuwe posities -9.5%
— formule
Geconcentreerde accumulatie — stijgende aandelen bij minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 162 | +3 | 50.44M | $18.07B | +8 | −4 |
| Q1 2026 | 161 | -2 | 49.75M | $12.46B | +4 | −7 |
| Q4 2025 | 162 | +3 | 53.70M | $14.74B | +5 | −1 |
| Q3 2025 | 21 | -1 | 26.99M | $7.08B | — | −2 |
| Q2 2025 | 20 | 0 | 24.84M | $5.43B | +1 | −1 |
| Q1 2025 | 17 | +2 | 8.37M | $1.87B | +2 | — |
| Q4 2024 | 15 | +2 | 8.55M | $2.80B | +2 | — |
| Q3 2024 | 12 | -1 | 4.43M | $1.33B | — | −1 |
| Q2 2024 | 13 | — | 5.33M | $1.75B | — | — |
Wie het bezit · Q3 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 9.70M | +4.2% | $2.55B | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passief) | 9.70M | +4.2% | $2.55B | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passief) | 9.70M | +4.2% | $2.55B | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passief) | 9.70M | +4.2% | $2.55B | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | The Vanguard Group ✦ (passief) | 9.70M | +4.2% | $2.55B | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 6.46M | -2.3% | $1.69B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 6.46M | -2.3% | $1.69B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 6.46M | -2.3% | $1.69B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 6.46M | -2.3% | $1.69B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 6.46M | -2.3% | $1.69B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 6.46M | -2.3% | $1.69B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 6.46M | -2.3% | $1.69B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 6.46M | -2.3% | $1.69B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 6.46M | -2.3% | $1.69B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 6.46M | -2.3% | $1.69B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 6.46M | -2.3% | $1.69B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 6.46M | -2.3% | $1.69B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | BlackRock ✦ (passief) | 6.46M | -2.3% | $1.69B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | BlackRock ✦ (passief) | 6.46M | -2.3% | $1.69B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | BlackRock ✦ (passief) | 6.46M | -2.3% | $1.69B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | BlackRock ✦ (passief) | 6.46M | -2.3% | $1.69B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | BlackRock ✦ (passief) | 6.46M | -2.3% | $1.69B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | BlackRock ✦ (passief) | 6.46M | -2.3% | $1.69B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | BlackRock ✦ (passief) | 6.46M | -2.3% | $1.69B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 25 | BlackRock ✦ (passief) | 6.46M | -2.3% | $1.69B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 26 | BlackRock ✦ (passief) | 6.46M | -2.3% | $1.69B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 27 | State Street Global Advisors ✦ (passief) | 3.21M | -1.9% | $841.53M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 28 | Geode Capital Management ✦ (passief) | 1.86M | +1.3% | $485.20M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 29 | Geode Capital Management ✦ (passief) | 1.86M | +1.3% | $485.20M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 1.48M | — | $387.89M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Morgan Stanley ✦ | 1.48M | — | $387.89M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Morgan Stanley ✦ | 1.48M | — | $387.89M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Morgan Stanley ✦ | 1.48M | — | $387.89M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Morgan Stanley ✦ | 1.48M | — | $387.89M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Morgan Stanley ✦ | 1.48M | — | $387.89M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Morgan Stanley ✦ | 1.48M | — | $387.89M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Morgan Stanley ✦ | 1.48M | — | $387.89M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | Morgan Stanley ✦ | 1.48M | — | $387.89M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | Morgan Stanley ✦ | 1.48M | — | $387.89M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Morgan Stanley ✦ | 1.48M | — | $387.89M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Morgan Stanley ✦ | 1.48M | — | $387.89M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Morgan Stanley ✦ | 1.48M | — | $387.89M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Morgan Stanley ✦ | 1.48M | — | $387.89M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | Morgan Stanley ✦ | 1.48M | — | $387.89M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | Morgan Stanley ✦ | 1.48M | — | $387.89M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Morgan Stanley ✦ | 1.48M | — | $387.89M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | Morgan Stanley ✦ | 1.48M | — | $387.89M | 0.0% | n/c | 1 | SEC ↗ |
| 48 | Morgan Stanley ✦ | 1.48M | — | $387.89M | 0.0% | n/c | 1 | SEC ↗ |
| 49 | Citadel Advisors ✦ | 727.54K | +464.9% | $190.85M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 50 | Citadel Advisors ✦ | 727.54K | +464.9% | $190.85M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 51 | Point72 Asset Management ✦ | 659.25K | +93.9% | $172.94M | 0.4% | ▲ Add | 4 | SEC ↗ |
| 52 | AQR Capital Management ✦ | 545.88K | +420.1% | $142.95M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 53 | AQR Capital Management ✦ | 545.88K | +420.1% | $142.95M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 54 | AQR Capital Management ✦ | 545.88K | +420.1% | $142.95M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 55 | AQR Capital Management ✦ | 545.88K | +420.1% | $142.95M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 56 | AQR Capital Management ✦ | 545.88K | +420.1% | $142.95M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 57 | AQR Capital Management ✦ | 545.88K | +420.1% | $142.95M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 58 | AQR Capital Management ✦ | 545.88K | +420.1% | $142.95M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 59 | AQR Capital Management ✦ | 545.88K | +420.1% | $142.95M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 60 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 61 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 62 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 63 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 64 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 65 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 66 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 67 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 68 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 69 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 70 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 71 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 72 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 73 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 74 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 75 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 76 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 77 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 78 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 79 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 80 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 81 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 82 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 83 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 84 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 85 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 86 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 87 | JPMorgan Chase ✦ | 473.93K | — | $124.33M | 0.0% | n/c | 1 | SEC ↗ |
| 88 | Gates Foundation Trust ✦ | 444.50K | 0.0% | $116.61M | 0.3% | Held | 3 | SEC ↗ |
| 89 | Goldman Sachs Group ✦ | 418.08K | — | $109.67M | 0.0% | n/c | 1 | SEC ↗ |
| 90 | Goldman Sachs Group ✦ | 418.08K | — | $109.67M | 0.0% | n/c | 1 | SEC ↗ |
| 91 | Goldman Sachs Group ✦ | 418.08K | — | $109.67M | 0.0% | n/c | 1 | SEC ↗ |
| 92 | Goldman Sachs Group ✦ | 418.08K | — | $109.67M | 0.0% | n/c | 1 | SEC ↗ |
| 93 | Goldman Sachs Group ✦ | 418.08K | — | $109.67M | 0.0% | n/c | 1 | SEC ↗ |
| 94 | Goldman Sachs Group ✦ | 418.08K | — | $109.67M | 0.0% | n/c | 1 | SEC ↗ |
| 95 | Millennium Management ✦ | 312.99K | -32.8% | $82.11M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 96 | Arrowstreet Capital ✦ | 220.96K | +71.2% | $57.97M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 97 | D. E. Shaw & Co. ✦ | 127.15K | -55.3% | $33.35M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 98 | T. Rowe Price ✦ | 114.55K | -2.6% | $30.05M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 99 | T. Rowe Price ✦ | 114.55K | -2.6% | $30.05M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 100 | Two Sigma Investments ✦ | 101.20K | -82.7% | $26.55M | 0.0% | ▼ Trim | 6 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Norges Bank | $200.81M | was 0.0% |
| Renaissance Technologies | $5.32M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 749 houders, 70.07M aandelen, $16.37B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Aug 06
SC 13G — FMR LLC
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q3 2025 ·
Methodologie ·
Verkrijg dit via de API